Praluent precio?

Praluent (alirocumab) – Price Overview

| Country | Typical List/Wholesale Price | Notes |
|---------|-----------------------------|-------|
| United States | ≈ $10 000 – $12 000 per year (≈ $833 – $1 000 per month) | List price; actual out‑of‑pocket cost depends on insurance, formulary placement, and patient‑specific benefit design. |
| Canada | ≈ $9 500 – $10 500 per year (CAD) | Public drug plans (e.g., provincial formularies) may cover a large portion; patient co‑payment varies. |
| United Kingdom | ≈ £8 000 – £9 000 per year (NHS list price) | NHS procurement can negotiate lower rates; patient co‑payment often minimal or waived. |
| Australia | ≈ AUD $10 000 – $12 000 per year | PBS (Pharmaceutical Benefits Scheme) pricing and patient co‑payment vary by subsidy level. |
| Europe (general) | ≈ €9 000 – €10 500 per year | National formularies set prices; co‑payment policies differ. |

What Does the Price Cover?

• Alirocumab drug product (the active PCSK9 inhibitor).
  
• Typically includes injection supplies (syringe, needle, pre‑filled syringe or vial).
  
• Administration (if given in a clinic) is not part of the drug list price; it incurs additional fees.
  
  

Why the Cost Is High

1. Novel Mechanism – PCSK9 inhibitors are a relatively new class of lipid‑lowering agents.
   
2. Clinical Trial Data – Extensive, multi‑center trials showing cardiovascular benefit.
   
3. Manufacturing Complexity – Biologic protein drug with stringent GMP requirements.
   
4. Limited Competition – No approved generic or biosimilar yet.
   
   

How to Reduce Out‑of‑Pocket Costs

• Insurance Coverage – Most commercial plans cover Praluent, sometimes after a prior‑authorization step. Check your formulary.
  
• Patient Assistance Programs – Amgen offers an assistance program for uninsured or under‑insured patients who meet income criteria.
  
• Copay Cards – Occasionally available; verify with pharmacy.
  
• Bulk Purchase Options – For patients receiving 2‑monthly dosing, some pharmacies may offer a single‑year supply discount.
  
  

Quick Tips

• Ask Your Pharmacist – They can provide the most current list price and explain co‑payment amounts.
  
• Check Your Plan’s Benefit Manager (PBM) – They may negotiate rebates that lower the patient cost.
  
• Look for Clinical Trial Enrollment – In some cases, patients can participate in ongoing trials that provide the drug free of charge.
  
  ---
  
  Bottom Line:
  Praluent is typically priced around $10k–$12k per year in the U.S., with similar ranges in other high‑income markets. Actual costs to patients vary widely depending on insurance coverage, subsidy programs, and local pricing agreements. Always consult your prescriber or pharmacist for the most accurate, personalized cost estimate.